Why this drug-research company’s stock is having its worst day since 1999
Icon’s stock is having its worst day since 1999, as an accounting probe added to investors’ worries about contract research…
Icon’s stock is having its worst day since 1999, as an accounting probe added to investors’ worries about contract research…